Skip to content

Efficacy of Red Light in Vitiligo

Efficacy of Red Light in Vitiligo: A Prospective, Single-Blind Randomized Controlled Trial

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01787708
Enrollment
16
Registered
2013-02-11
Start date
2013-02-28
Completion date
Unknown
Last updated
2015-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitiligo

Keywords

Vitiligo, red, laser, light

Brief summary

Vitiligo is a chronic acquired disease characterized by well defined white macules and patches affecting the skin. There are many treatment modalities available for vitiligo, however, none of them cure the disease. Visible red light has been shown to stimulates melanocyte migration and proliferation resulting in repigmentation of vitiligo patches. However, there are only a few studies published on the efficacy of red light in vitiligo. This is a prospective single-blind randomized clinical trial to assess efficacy of red light in the treatment of vitiligo.

Detailed description

Vitiligo is a chronic acquired disease characterized by well defined white macules and patches affecting the skin and mucous membranes. Mucocutaneous lesions develop secondary to selective destruction of melanocytes. The etiology of vitiligo is largely unknown but more likely to be multifactorial. There are several theories on the pathogenesis of vitiligo including mainly the autoimmune, neurohormonal, and autocytotoxic theories. The autoimmune hypothesis has the strongest evidence with alteration mainly in the cellular immune response. There are many treatment modalities available for vitiligo, however, none of them cure the disease. These include different topical treatments, phototherapy, surgical therapy, and depigmentation therapy. Visible red light has been shown to stimulates melanocyte migration and proliferation resulting in repigmentation of vitiligo patches. However, there are only a few studies published on the efficacy of red light in vitiligo. The investigators plan on conducting a prospective single-blind randomized clinical trial to assess efficacy of red light in the treatment of vitiligo. Study Objective To evaluate the potential for red light to induce repigmentation within vitiligo patches.

Interventions

PROCEDURERed light

Sponsors

University of British Columbia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years. * Localized or generalized vitiligo that involves a non mucosal or acral site. * Patients should have a patch of at least 25 cm2 that shows no more than 10% repigmentation as assessed visually

Exclusion criteria

* Patients who received treatment for vitiligo within the past 3 weeks. * Patients known to have a photosensitivity disorder * History of previous skin cancer. * History of severe medical illness or immunosuppression. * Pregnancy or breast-feeding.

Design outcomes

Primary

MeasureTime frame
Change in the modified VASI score compared to baseline.assessments at 2, 4, 6, 8 and 10 weeks during treatment then at 4, 8, and 12 weeks post treatment

Countries

Canada

Contacts

Primary ContactHarvey Lui, MD, FRCPC
harvey.lui@ubc.ca16048754111

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026